PAE vs sham
- Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic… 2022 · Cochrane Headline outcomes onlyno estimate extracted1 study · 80 participantsVery low
It is very uncertain whether PAE changes major adverse events compared with TURP (very low certainty).
It is very uncertain whether PAE changes major adverse events compared with TURP (very low certainty).
Transurethral microwave thermotherapy probably leads to lower major adverse events compared with transurethral resection of the prostate (moderate certainty).
It is very uncertain whether convective radiofrequency water vapour thermal therapy changes major adverse events compared with sham procedure (very low certainty).
It is very uncertain whether PUL changes major adverse events compared with sham (very low certainty).
It is very uncertain whether PUL changes major adverse events compared with TURP (very low certainty).
It is very uncertain whether aquablation changes major adverse events compared with transurethral resection of the prostate (very low certainty).
It is very uncertain whether whole gland primary cryotherapy changes major adverse events compared with external beam radiotherapy (EBRT) (very low certainty).
Alpha‐blockers showed no clear difference in major adverse events compared with standard therapy (low certainty).
Alpha‐blockers probably leads to higher major adverse events compared with placebo (moderate certainty).
Desmopressin showed no clear difference in major adverse events compared with placebo (low certainty).
Desmopressin plus alpha‐blocker showed no clear difference in major adverse events compared with alpha‐blocker (low certainty).
Alvimopan probably leads to lower major adverse events compared with placebo (moderate certainty).
The review found no eligible studies for this question.